Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06522607

3D Analysis of Palatal Morphology of Growing Patients Treated With Rapid Palatal Expander.

Three-dimensional Analysis of Palatal Morphology of Hypo-, Hyper-, Normodivergent Growing Subjects With Posterior Cross-bite Treated With Rapid Palatal Expander, a Longitudinal Pilot Study.

Status
Recruiting
Phase
Study type
Observational
Enrollment
36 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
7 Years – 15 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study is to assess the changes of palatal morphology among growing patients with different vertical facial growth patterns treated with rapid palatal expander. Thirty-six patients referred to "Policlinico Agostino Gemelli" university hospital will be selected. The eligible criteria are posterior cross-bite, mixed dentition, skeletal Class I relationship and prepubertal stage of cervical vertebral maturation. The patients will be split into three groups according to facial divergency (hyper-, hypo-, normodivergent subjects). For each subject, digital dental casts will be recorded before and after treatment using an intraoral scanner. To evaluate two-dimensional maxillary arch changes, linear measurements will be done. To study comprehensively the palatal shape, a set of 240 landmark and semi-landmarks will be digitized on the palatal vault. Then, Geometric Morphometric Analysis (GMA) will be performed to compare morphological variations of the palate among different vertical facial growth pattern groups.

Conditions

Interventions

TypeNameDescription
DEVICErapid palatal expanderClinical evaluation of the patients who will be treated with rapid palatal expander for about 6 month.

Timeline

Start date
2024-07-17
Primary completion
2026-07-31
Completion
2026-12-31
First posted
2024-07-26
Last updated
2025-09-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06522607. Inclusion in this directory is not an endorsement.